Monoclonal antibody used for Muckle-Wells syndrome is: (A) Canakinumab, (B) Catumaxomab, (C) Ceolizumab, (D) Cetuximab
Answer is A. Canakinumab: Against IL-1b Used in Muckle-Wells syndrome Muckle-Wells syndrome =Sensorineural deafness =Recurrent hives =Amyloidosis Catumaxomab Bispecific mAb Used in Malignant ascites Ceolizumab: Again stTNF Used in Crohn disease Cetuximab Against EGFR Used in Colorectal cancer